 Connection
Bradley Warady to Angiotensin II Type 1 Receptor Blockers
This is a "connection" page, showing publications Bradley Warady has written about Angiotensin II Type 1 Receptor Blockers.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.268 |
|
|
|
-
Abraham AG, Betoko A, Fadrowski JJ, Pierce C, Furth SL, Warady BA, Mu?oz A. Renin-angiotensin II-aldosterone system blockers and time to renal replacement therapy in children with CKD. Pediatr Nephrol. 2017 04; 32(4):643-649.
Score: 0.142
-
Blowey DL, Warady BA. Outcome of infants born to women with chronic kidney disease. Adv Chronic Kidney Dis. 2007 Apr; 14(2):199-205.
Score: 0.073
-
Ha IS, Yap HK, Munarriz RL, Zambrano PH, Flynn JT, Bilge I, Szczepanska M, Lai WM, Antonio ZL, Gulati A, Hooman N, van Hoeck K, Higuita LM, Verrina E, Klaus G, Fischbach M, Riyami MA, Sahpazova E, Sander A, Warady BA, Schaefer F. Risk factors for loss of residual renal function in children treated with chronic peritoneal dialysis. Kidney Int. 2015 Sep; 88(3):605-13.
Score: 0.032
-
Wong CS, Pierce CB, Cole SR, Warady BA, Mak RH, Benador NM, Kaskel F, Furth SL, Schwartz GJ. Association of proteinuria with race, cause of chronic kidney disease, and glomerular filtration rate in the chronic kidney disease in children study. Clin J Am Soc Nephrol. 2009 Apr; 4(4):812-9.
Score: 0.021
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|